NEW YORK (GenomeWeb News) — Luminex today said it plans to acquire Canadian molecular diagnostic company Tm Bioscience in a stock-for-stock deal.
 
Luminex said it plans to use what it calls Tm’s “strong menu of kits and reagents” with its own business connections to enhance its sales by getting Tm’s products to wider markets.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.